Gubra is a biotech company delivering pre-clinical contract research services within obesity, diabetes and NASH. We combine cutting-edge technology, our accumulated experience and proven methodology to challenge current beliefs.

Watch our short video to learn more about the Gubra approach to Laser Capture Microscopy.

Gubra has established and validated a diet-induced obese mouse model of NAFLD/NASH disease for chronic efficacy studies.
Read more here.

Gubra is hiring. See our open positions here.